- Home
- ZJYL vs KTTA Comparison
ZJYL vs KTTA Comparison
Compare ZJYL & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZJYL | KTTA |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 26.7M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZJYL | KTTA |
|---|---|---|
| Price | $0.16 | $0.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 1.3M | 247.2K |
| Earning Date | 08-20-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $22,826,624.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.19 | ★ N/A |
| Revenue Growth | ★ 13.42 | N/A |
| 52 Week Low | $0.11 | $0.28 |
| 52 Week High | $1.03 | $3.85 |
Technical Indicators
Market Signals| Indicator | ZJYL | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 39.35 | 38.50 |
| Support Level | $0.12 | $0.83 |
| Resistance Level | $0.18 | $0.92 |
| Average True Range (ATR) | 0.03 | 0.05 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 30.12 | 29.01 |
Price Performance
Historical ComparisonAbout ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).